Total Payments
$1,451
2024 Payments
$539.33
Companies
14
Transactions
70
Medicare Patients
4,888
Medicare Billing
$852,845
Payment Breakdown by Category
Food & Beverage$1,222 (84.2%)
Education$228.99 (15.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,222 | 67 | 84.2% |
| Education | $228.99 | 3 | 15.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $409.10 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $404.53 | 15 | $0 (2024) |
| Amgen Inc. | $171.78 | 8 | $0 (2024) |
| Lilly USA, LLC | $119.18 | 6 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $49.64 | 2 | $0 (2018) |
| AbbVie Inc. | $45.10 | 3 | $0 (2021) |
| GENZYME CORPORATION | $42.73 | 2 | $0 (2024) |
| Galderma Laboratories, L.P. | $41.62 | 3 | $0 (2022) |
| Incyte Corporation | $40.11 | 2 | $0 (2022) |
| UCB, Inc. | $34.24 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $539.33 | 27 | Novartis Pharmaceuticals Corporation ($312.38) |
| 2023 | $387.23 | 19 | Janssen Biotech, Inc. ($179.50) |
| 2022 | $248.69 | 10 | Janssen Biotech, Inc. ($72.00) |
| 2021 | $47.68 | 2 | Amgen Inc. ($33.41) |
| 2018 | $20.72 | 1 | Regeneron Healthcare Solutions, Inc. ($20.72) |
| 2017 | $206.88 | 11 | Lilly USA, LLC ($79.92) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $9.87 | General |
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $99.88 | General |
| 10/29/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.58 | General |
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Dermatology | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Dermatology | ||||||
| 07/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Immunology | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Dermatology | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: Dermatology | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Dermatology | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: Dermatology | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Dermatology | ||||||
| 05/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Inflammation | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Dermatology | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Dermatology | ||||||
| 05/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Inflammation | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Dermatology | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Dermatology | ||||||
| 04/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Immunology | ||||||
| 03/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Dermatology | ||||||
| 03/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,245 | 1,870 | $862,679 | $291,065 |
| 2022 | 26 | 1,817 | 2,690 | $917,613 | $294,763 |
| 2021 | 17 | 981 | 1,488 | $514,958 | $140,034 |
| 2020 | 16 | 845 | 1,280 | $538,473 | $126,982 |
Total Patients
4,888
Total Services
7,328
Medicare Billing
$852,845
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 231 | 271 | $377,469 | $131,250 | 34.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 117 | 163 | $139,887 | $54,153 | 38.7% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 30 | 33 | $43,165 | $16,323 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 216 | $39,518 | $13,387 | 33.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 132 | 170 | $35,695 | $11,463 | 32.1% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 16 | 16 | $25,040 | $9,692 | 38.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 66 | 67 | $43,617 | $8,671 | 19.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 54 | 56 | $35,041 | $8,662 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 94 | $24,252 | $8,640 | 35.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 44 | 49 | $11,515 | $4,048 | 35.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 52 | 95 | $9,871 | $3,792 | 38.4% |
| 12053 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | Office | 2023 | 23 | 23 | $17,273 | $3,678 | 21.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 75 | 96 | $13,245 | $3,277 | 24.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 17 | 18 | $11,469 | $2,449 | 21.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 15 | 18 | $6,264 | $2,314 | 36.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 58 | 403 | $5,588 | $2,128 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,376 | $1,961 | 36.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $4,404 | $1,728 | 39.2% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 12 | 12 | $7,020 | $1,377 | 19.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 20 | $2,300 | $899.60 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,486 | $650.12 | 26.2% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $2,184 | $522.35 | 23.9% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 189 | 212 | $291,924 | $94,758 | 32.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 80 | 113 | $95,010 | $36,728 | 38.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 254 | 329 | $69,748 | $20,927 | 30.0% |
About Dr. Andrea Smith, M.D
Dr. Andrea Smith, M.D is a MOHS-Micrographic Surgery healthcare provider based in Poulsbo, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1801064969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrea Smith, M.D has received a total of $1,451 in payments from pharmaceutical and medical device companies, with $539.33 received in 2024. These payments were reported across 70 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,222).
As a Medicare-enrolled provider, Smith has provided services to 4,888 Medicare beneficiaries, totaling 7,328 services with total Medicare billing of $852,845. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Procedural Dermatology, Dermatology
- Location Poulsbo, WA
- Active Since 02/12/2008
- Last Updated 06/24/2022
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1801064969
Products in Payments
- TREMFYA (Drug) $404.53
- COSENTYX (Drug) $242.88
- Otezla (Drug) $171.78
- TALTZ (Drug) $119.18
- DUPIXENT DUPILUMAB INJECTION (Biological) $49.64
- DUPIXENT (Biological) $42.73
- OPZELURA (Drug) $40.11
- Cimzia (Drug) $34.24
- COSENTYX (Biological) $32.89
- Winlevi (Drug) $32.08
- Humira (Biological) $30.83
- Sotyktu (Drug) $24.79
- SpaceOAR VUE System - 10mL (Device) $15.92
- ORACEA (Drug) $14.78
- SKYRIZI (Biological) $14.27
- SOOLANTRA (Drug) $12.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.